Brainstorm Cell Therapeutics Inc. (BCLI) Operating income 2016–2025
Brainstorm Cell Therapeutics Inc. (BCLI) annual operating income history from SEC filings — each fiscal year as reported.
-$10.0MFY2025 · since FY2016: -$5.1M → -$10.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$10.0M | +14.9% |
| FY2024 | -$11.7M | +45.5% |
| FY2023 | -$21.4M | +13.6% |
| FY2022 | -$24.8M | -1.2% |
| FY2021 | -$24.5M | +22.6% |
| FY2020 | -$31.7M | -37.8% |
| FY2019 | -$23.0M | -63.6% |
| FY2018 | -$14.1M | -181.3% |
| FY2017 | -$5.0M | +1.7% |
| FY2016 | -$5.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice